Eagle Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,957
| Closed | -$117K | – | 561 |
|
|
2023
Q4 | $117K | Buy |
25,957
+4,367
| +20% | +$19.7K | ﹤0.01% | 548 |
|
|
2023
Q3 | $77.3K | Hold |
21,590
| – | – | ﹤0.01% | 530 |
|
|
2023
Q2 | $79.7K | Buy |
21,590
+2,217
| +11% | +$8.18K | ﹤0.01% | 526 |
|
|
2023
Q1 | $64K | Buy |
19,373
+6,544
| +51% | +$21.6K | ﹤0.01% | 537 |
|
|
2022
Q4 | $49K | Buy |
+12,829
| New | +$49K | ﹤0.01% | 528 |
|
|
2022
Q3 | – | Sell |
-28,833
| Closed | -$57K | – | 545 |
|
|
2022
Q2 | $57K | Hold |
28,833
| – | – | ﹤0.01% | 552 |
|
|
2022
Q1 | $52K | Buy |
28,833
+10,281
| +55% | +$18.5K | ﹤0.01% | 572 |
|
|
2021
Q4 | $24K | Hold |
18,552
| – | – | ﹤0.01% | 596 |
|
|
2021
Q3 | $20K | Hold |
18,552
| – | – | ﹤0.01% | 590 |
|
|
2021
Q2 | $29K | Hold |
18,552
| – | – | ﹤0.01% | 597 |
|
|
2021
Q1 | $33K | Buy |
18,552
+2,310
| +14% | +$4.11K | ﹤0.01% | 591 |
|
|
2020
Q4 | $31K | Buy |
16,242
+5,790
| +55% | +$11.1K | ﹤0.01% | 551 |
|
|
2020
Q3 | $22K | Buy |
+10,452
| New | +$22K | ﹤0.01% | 567 |
|